# An Updated Wearable Magnetic Flux Device to Optimize Blood Pressure Control

Study · id `cardio:ct-nct05866445` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05866445](<https://clinicaltrials.gov/study/NCT05866445>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05866445

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

## Technical summary

Registry record NCT05866445. Randomized; triple masking; primary purpose treatment. Start 2023-03-15 (actual); primary completion 2025-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 180 participants (enrolled count; ClinicalTrials.gov record NCT05866445, source copy `cardio:ctgov-nct05866445-2025-06-05`, retrieved 2026-10-26)
- Started: 2023-03-15 (actual) (ClinicalTrials.gov record NCT05866445, source copy `cardio:ctgov-nct05866445-2025-06-05`, retrieved 2026-10-26)
- Primary completion: 2025-04-30 (actual) (ClinicalTrials.gov record NCT05866445, source copy `cardio:ctgov-nct05866445-2025-06-05`, retrieved 2026-10-26)
- Completion: 2025-04-30 (actual) (ClinicalTrials.gov record NCT05866445, source copy `cardio:ctgov-nct05866445-2025-06-05`, retrieved 2026-10-26)
- Countries: Singapore (ClinicalTrials.gov record NCT05866445, source copy `cardio:ctgov-nct05866445-2025-06-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05866445-2025-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: An Updated Wearable Magnetic Flux Device to Optimize Blood Pressure Control
- Condition: Hypertension
- Intervention (Device): Wearable BP device
- Intervention (Device): 24-hour ambulatory blood pressure monitor
- Lead sponsor: National Heart Centre Singapore
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: National Heart Centre Singapore (`cardio:org-national-heart-centre-singapore`)

## Provenance

Content hash: 92fe5158e2bdaf5df904d6b4ac6d8d614f9198a8719b7b53713f29fd8ad21e35
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
